share

Efrapeptin B CAS NO 138145-53-6


Unit Price:

CAS No.:138145-53-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Efrapeptin B CAS NO 138145-53-6 is a potent, naturally occurring peptaibol antibiotic complex produced by the fungus Tolypocladium. This compound is highly valued for its specific inhibitory activity against mitochondrial F1F0-ATPase, making it a critical research tool in bioenergetics and cell biology. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and biotechnology companies investigating mitochondrial function, ATP synthesis, and novel antimicrobial agents.

Application

  • Biochemical Research: A specific and potent inhibitor of mitochondrial ATP synthase (F1F0-ATPase), used to study oxidative phosphorylation, cellular energetics, and ion transport.
  • Cell Biology & Physiology: Employed in experiments to probe mitochondrial function, membrane potential, and the role of ATP in cellular processes like apoptosis and signal transduction.
  • Antimicrobial Studies: Investigated for its intrinsic antifungal and antibacterial properties, serving as a lead compound or reference standard in the development of new antimicrobial agents.
  • Insecticidal Research: Used in agricultural and entomological research due to its known toxicity against certain insect species, exploring potential biopesticide applications.
  • Pharmaceutical Development: Serves as a reference standard in drug discovery pipelines targeting mitochondrial dysfunction, metabolic diseases, or infectious diseases.
  • Enzyme Mechanism Studies: A crucial tool for enzymologists to elucidate the catalytic mechanism and structure-function relationships of the ATP synthase complex.

Basic Information

Product Name Efrapeptin B
CAS No. 138145-53-6
Molecular Formula C58H95N15O14
Molecular Weight 1210.5 g/mol
Synonyms Efrapeptin B; Antibiotic LL-AF283B β; Efrapeptin B complex; ATPase inhibitor, Efrapeptin B; Peptaibol LL-AF283B β; Tolypocladium antibiotic B; F1F0-ATPase inhibitor (Efrapeptin B)
EINECS Contact for details

Quality Control

Our Efrapeptin B is produced and handled under strict quality management protocols to ensure batch-to-batch consistency and reliability for research applications. Each lot is characterized using advanced analytical techniques including HPLC for purity assessment and mass spectrometry for identity confirmation. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and other relevant parameters is provided with every shipment to support your research documentation and compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to prevent moisture absorption.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC/MS) Conforms to reference standard
Purity (HPLC) ≥ 95.0%
Water Content (KF) ≤ 5.0%
Biological Activity (ATPase Inhibition) IC50 provided on COA

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.